| 2801 |
Cord Blood |
Autologous |
Hydrocephalus |
Neurology |
2022 |
Experimental Therapy |
Romania |
6 |
| 2802 |
Cord Blood |
Allogeneic – Related |
Sickle Cell Anemia |
Hematology |
2022 |
Standard Therapy |
Turkey |
7,7 |
| 2803 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2022 |
Standard Therapy |
Turkey |
19,2 |
| 2804 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 2805 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
68 |
| 2806 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2807 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
41 |
| 2808 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 2809 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
79 |
| 2810 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
23 |
| 2811 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
62 |
| 2812 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
60 |
| 2813 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
56 |
| 2814 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
46 |
| 2815 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
41 |
| 2816 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
62 |
| 2817 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
43 |
| 2818 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
54 |
| 2819 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
65 |
| 2820 |
Bone Marrow Family |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
54 |
| 2821 |
Bone Marrow Family |
Allogeneic |
Blastic Plasmacytoid Dendritic Cell Neoplasm |
Hematology |
2022 |
Standard Therapy |
Poland |
55 |
| 2822 |
Bone Marrow Family |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 2823 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
60 |
| 2824 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia, Type 2 |
Hematology |
2022 |
Standard Therapy |
Poland |
68 |
| 2825 |
Bone Marrow Family |
Allogeneic |
Leukocyte Adhesion Deficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
33 |
| 2826 |
Bone Marrow Family |
Allogeneic |
Mycosis Fungoides |
Hematology |
2022 |
Standard Therapy |
Poland |
62 |
| 2827 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
71 |
| 2828 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
66 |
| 2829 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
29 |
| 2830 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
67 |
| 2831 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
71 |
| 2832 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
69 |
| 2833 |
Bone Marrow Family |
Allogeneic |
Myelofibrosis |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 2834 |
Bone Marrow Family |
Allogeneic |
Myelofibrosis Post Essential Thrombocythemia |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 2835 |
Bone Marrow Family |
Allogeneic |
Myeloma Multiplex |
Hematology |
2022 |
Standard Therapy |
Poland |
49 |
| 2836 |
Bone Marrow Family |
Allogeneic |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
73 |
| 2837 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 2838 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
2 |
| 2839 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
37 |
| 2840 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
16 |
| 2841 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
9 |
| 2842 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
14 |
| 2843 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2844 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
6 |
| 2845 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
38 |
| 2846 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
10 |
| 2847 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
10 |
| 2848 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
13 |
| 2849 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
4 |
| 2850 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
25 |
| 2851 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
8 |
| 2852 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
6 |
| 2853 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
20 |
| 2854 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
13 |
| 2855 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
13 |
| 2856 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
15 |
| 2857 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2858 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
15 |
| 2859 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2860 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2861 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2862 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
12 |
| 2863 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
44 |
| 2864 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2865 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
75 |
| 2866 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
61 |
| 2867 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
41 |
| 2868 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
23 |
| 2869 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
36 |
| 2870 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
17 |
| 2871 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
63 |
| 2872 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
63 |
| 2873 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
12 |
| 2874 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
16 |
| 2875 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
58 |
| 2876 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
68 |
| 2877 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
25 |
| 2878 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
30 |
| 2879 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2880 |
Bone Marrow |
Allogeneic |
Adenosine Deaminase Deficient Severe Combined Immunodeficiency (Ada-Scid) |
Hematology |
2022 |
Standard Therapy |
Poland |
3 months |
| 2881 |
Bone Marrow |
Allogeneic |
Amyloidosis |
Hematology |
2022 |
Standard Therapy |
Poland |
9 |
| 2882 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
19 |
| 2883 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
49 |
| 2884 |
Bone Marrow |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
10 |
| 2885 |
Bone Marrow |
Allogeneic |
Bone Marrow Failure Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2886 |
Bone Marrow |
Allogeneic |
Chediak-Higashi-Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
10 |
| 2887 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2022 |
Standard Therapy |
Poland |
37 |
| 2888 |
Bone Marrow |
Allogeneic |
Combined Immunodeficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
7 |
| 2889 |
Bone Marrow |
Allogeneic |
Common Variable Immunodeficiency With Granulomatous-Lymphocytic Interstitial Lung Disease |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2890 |
Bone Marrow |
Allogeneic |
Diamond Blackfan Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2891 |
Bone Marrow |
Allogeneic |
Diamond Blackfan Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
4 |
| 2892 |
Bone Marrow |
Allogeneic |
Dock8 Deficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2893 |
Bone Marrow |
Allogeneic |
Early Isolated All Bm Relapse |
Hematology |
2022 |
Standard Therapy |
Poland |
6 |
| 2894 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
5 |
| 2895 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
7 |
| 2896 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
16 |
| 2897 |
Bone Marrow |
Allogeneic |
Griscelli Syndrome Type 2 |
Hematology |
2022 |
Standard Therapy |
Poland |
2 months |
| 2898 |
Bone Marrow |
Allogeneic |
Hemophagocytic Lymphocytosis |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2899 |
Bone Marrow |
Allogeneic |
Hemophagocytic Lymphohistiocytosis (Hlh) |
Hematology |
2022 |
Standard Therapy |
Poland |
46 |
| 2900 |
Bone Marrow |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
57 |